Posterior fossa meningiomas: perioperative predictors of extent of resection, overall survival and progression-free survival

被引：0
作者：
Marco V. Corniola
Jean-Michel Lemée
Michele Da Broi
Holger Joswig
Karl Schaller
Eirik Helseth
Torstein R. Meling
机构：
[1] Geneva University Hospitals,Department of Clinical Neurosciences, Division of Neurosurgery
[2] University of Oslo,Faculty of Medicine
[3] University of Geneva,Faculty of Medicine
[4] Oslo University Hospital,Department of Neurosurgery
来源：
Acta Neurochirurgica | 2019年 / 161卷
关键词：
Posterior Fossa; Meningioma; Overall survival; Progression-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1003 / 1011
页数：8
相关论文
共 50 条
  • [21] Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Halabi, Susan
    Rini, Brian
    Escudier, Bernard
    Stadler, Walter M.
    Small, Eric J.
    CANCER, 2014, 120 (01) : 52 - 60
  • [22] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Chirila, Costel
    Odom, Dawn
    Devercelli, Giovanna
    Khan, Shahnaz
    Sherif, Bintu N.
    Kaye, James A.
    Molnar, Istvan
    Sherrill, Beth
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (05) : 623 - 634
  • [23] Joint modeling of progression-free survival and overall survival by a Bayesian normal induced copula estimation model
    Fu, Haoda
    Wang, Yanping
    Liu, Jingyi
    Kulkarni, Pandurang M.
    Melemed, Allen S.
    STATISTICS IN MEDICINE, 2013, 32 (02) : 240 - 254
  • [24] Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer
    Costel Chirila
    Dawn Odom
    Giovanna Devercelli
    Shahnaz Khan
    Bintu N. Sherif
    James A. Kaye
    István Molnár
    Beth Sherrill
    International Journal of Colorectal Disease, 2012, 27 : 623 - 634
  • [25] Progression-Free Survival, Prognostic Factors, and Surgical Outcome of Spheno-Orbital Meningiomas
    Masalha, Waseem
    Heiland, Dieter Henrik
    Steiert, Christine
    Krueger, Marie T.
    Schnell, Daniel
    Scheiwe, Christian
    Schnell, Oliver
    Grosu, Anca-L
    Beck, Juergen
    Grauvogel, Juergen
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Rethinking Progression-Free Survival (PFS) as a Clinical Trials Surrogate for Overall Survival (OS)
    Stewart, D.
    Bosse, D.
    Ocana, A.
    Goss, G.
    Jonker, D.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1782 - S1782
  • [27] Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
    Li, Jiayi
    Cao, Dongyan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, Vera
    Schuett, Philipp
    Brandhorst, Dieter
    Opalka, Bertram
    Moritz, Thomas
    Nowrousian, Mohammad Reza
    Grosse-Wilde, Hans
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 114 - 120
  • [29] Quantifying the association between progression-free survival and overall survival in oncology trials using Kendall's τ
    Weber, Enya M.
    Titman, Andrew C.
    STATISTICS IN MEDICINE, 2019, 38 (05) : 703 - 719
  • [30] Overall Survival: A Gold Standard in Search of a Surrogate The Value of Progression-Free Survival and Time to Progression as End Points of Drug Efficacy
    Zhuang, Sen H.
    Xiu, Liang
    Elsayed, Yusri A.
    CANCER JOURNAL, 2009, 15 (05) : 395 - 400
12345